CClinicalTrials.gg
CompletedNCT00256594Updated Dec 15, 2011

Evaluation of an Outpatient Modified Prescription Form

An interventional study of prescription form in Medication Errors, sponsored by University of Vermont. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-12-15.

Sponsored by University of Vermont · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine if a modified paper prescribing form decreases prescribing errors compared to a traditional or standard paper prescribing form.

Read the detailed description

The broad goal of this proposal is to reduce outpatient prescribing errors in rural primary care practices. Although computerized technology is available for prescribing, it has not yet been implemented in most settings. Additionally, rural prescribers will likely be the last to have the means to adopt this technology. Due to the substantial morbidity and mortality in the United States caused by outpatient medication errors, there is an urgent need for low-cost solutions. This research plan will evaluate a modified paper prescription form that may be implemented in rural primary care settings cheaply and quickly with the goal of outpatient prescription error reduction.

The specific aims of this project are:

  1. To determine if a modified paper prescription form decreases overall prescribing errors compared to a standard paper prescription form
  2. To determine if a modified paper prescription form decreases omission errors compared to a standard paper prescription form
  3. To determine prescriber satisfaction with the modified prescription form

Rural prescribers from four states will be randomly recruited to write prescriptions on standard and modified forms. Prescription duplicates of both types will be analyzed for errors. Prescriber satisfaction with the modified form will be evaluated using surveys and focus groups.

Medication errors are a public health problem. Low-cost technology that is shown to reduce medication errors would benefit all rural patients who receive prescriptions.

02

Conditions studied

  • Medication Errors

Keywords

  • Medical Errors
  • Medication Errors
  • Prescriptions, Drug
03

In context

Lead sponsor

University of Vermont is the lead sponsor of 215 studies on the registry; 28 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 9 (56%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Must be a physician, nurse practitioner, or physician assistant with a current license to write outpatient prescriptions
  • Must practice in Family Practice, Internal Medicine, or Pediatrics
  • Must practice in rural Vermont, West Virginia, South Dakota, or Montana
  • Must write outpatient paper prescriptions
  • Must write prescriptions in English

Exclusion criteria

Exclusion Criteria:

  • Not licensed to write prescriptions
  • Practice in a specialty, inpatient, or long term care setting
  • Do not write paper prescriptions
  • Do not write prescriptions in English
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
84 participants (actual)

Interventions

  • Deviceprescription form

    Two prescription pads contained modified forms and two prescription pads were similar to the prescription pads the prescriber had been using. Providers completed 100 standard and 100 modified prescriptions

06

What researchers measure

Primary outcomes

  1. error rates of standard versus modified prescriptions per prescriber

    Time frame: 200 prescriptions each

07

Study locations

1 site
  • University of Vermont, Division of General Internal Medicine
    Burlington, Vermont 05401, United States
08

References and documents

Publications

  • Kennedy AG, Littenberg B. A modified outpatient prescription form to reduce prescription errors. Jt Comm J Qual Saf. 2004 Sep;30(9):480-7. doi: 10.1016/s1549-3741(04)30056-0. PubMed 15469125 ↗
  • Kennedy AG, Littenberg B, Callas PW, Carney JK. Evaluation of a modified prescription form to address prescribing errors. Am J Health Syst Pharm. 2011 Jan 15;68(2):151-7. doi: 10.2146/ajhp100063. PubMed 21200063 ↗
  • Kennedy AG, Senders JW, Sellen K, Littenberg B, Callas PW, Carney JK. Perception of drug-name legibility by pharmacists and pharmacy technicians. Am J Health Syst Pharm. 2009 May 1;66(9):794-5. doi: 10.2146/ajhp080189. No abstract available. PubMed 19386937 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00256594
Lead sponsor
University of Vermont
Collaborators
Health Resources and Services Administration (HRSA)
Responsible party
Amanda Kennedy (Assistant Professor of Medicine, University of Vermont) — Principal investigator
First posted
Nov 21, 2005
Start date
Aug 2005
Primary completion
Feb 2010
Completion
Jan 2011
Last update
Dec 15, 2011

Study contacts

Amanda G Kennedy, PharmD
principal investigator · University of Vermont

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion